<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>moderna — GZERO Media</title>
<link>https://www.gzeromedia.com/tag/moderna</link>
<description>The latest news and analysis from GZERO Media.</description>
<language>en</language>
<copyright>© GZERO Media</copyright>
<atom:link href="https://www.gzeromedia.com/feeds/tag/moderna.xml" rel="self" type="application/rss+xml" />
<lastBuildDate>Thu, 17 Feb 2022 20:06:20 +0000</lastBuildDate>
<item>
<title>What We&apos;re Watching: Harris goes to Munich, French troops quit Mali, Japan&apos;s soft opening, Africa&apos;s mRNA mission</title>
<link>https://www.gzeromedia.com/news/what-we-re-watching-harris-goes-to-munich-french-troops-quit-mali-japan-s-soft-opening-africa-s-mrna-mission</link>
<guid isPermaLink="false">cmvrev0eyh08z07my44us9hje</guid>
<pubDate>Thu, 17 Feb 2022 20:06:20 +0000</pubDate>
<dc:creator>Gabrielle Debinski, Alex Kliment, Tracy Moran</dc:creator>
<category>munich security conference</category>
<category>moderna</category>
<category>france</category>
<category>sahel</category>
<category>mali</category>
<category>africa</category>
<category>covid-19</category>
<category>kamala harris</category>
<category>News</category>
<description>Harris goes back to the future in Bavaria.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb46fu8r1h07myft907qun" type="image/jpeg" medium="image" width="4274" height="2844">
<media:credit>Michael Brochstein/Sipa USA</media:credit>
<media:text>US Vice President Kamala Harris</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrb46fu8r1h07myft907qun" />
<content:encoded><![CDATA[<p><strong>Harris goes back to the future in Bavaria.</strong> In recent years, the Munich Security Conference (MSC) – to say nothing of the broader transatlantic alliance – have suffered from a sense of unclear purpose. US President Donald Trump questioned NATO’s value, and French President Emmanuel Macron has called it “brain-dead.” Without the Cold War framework, many have asked whether <a href="https://www.gzeromedia.com/a-summit-of-the-brain-dead">NATO even has a purpose</a>? But things couldn’t feel more different today, according to Eurasia Group President Ian Bremmer. “You’re talking about US leadership and an alliance that feels unprecedentedly threatened by the recent escalation in Ukraine from Russia,” said Bremmer from Munich on Thursday. And the face of that US leadership at Munich this year is US Vice President Kamala Harris, who will deliver an important address on Saturday. Harris, who was also tasked with handling the challenge of migration at the US-Mexico border last year, has struggled to shine in her historic role as the first female Veep. A powerful address at Munich, delivered in the thick of a major transatlantic security crisis, could be her moment in the sun.</p><p><strong>French troops quit Mali.</strong> French and allied troops<a rel="noopener noreferrer" target="_blank" href="https://www.bbc.com/news/world-africa-60414003"> will leave</a> Mali this year, ending a nearly decade-long deployment in the unstable West African nation aimed at quashing jihadist groups in the Sahel. Since an<a href="https://www.gzeromedia.com/inside-malis-deep-crisis"> August 2020 coup</a>, Mali has been run by a junta that has clashed with Paris, the former colonial power, over a range of security and political issues. Most recently, the junta postponed elections, which led to a spat and expulsion of the French ambassador. Many of the roughly 2,000 French troops in Mali will redeploy to <a rel="noopener noreferrer" target="_blank" href="https://abcnews.go.com/International/wireStory/eu-nations-withdraw-military-task-force-mali-82948755">neighboring Niger</a>, French President Emmanuel Macron said Thursday. But keep an eye on Mali for what happens with two key players: jihadist groups and the Russian mercenaries whose presence there (and<a href="https://www.gzeromedia.com/putins-push-in-africa"> elsewhere</a> in Africa) is<a rel="noopener noreferrer" target="_blank" href="https://www.france24.com/en/live-news/20220217-macron-warns-of-predatory-russian-mercenaries-in-mali"> irking Europe</a>.</p><p><strong>Japan eases “seclusion.”</strong> After two years of nearly total isolation, the Land of the Rising Sun will <a rel="noopener noreferrer" target="_blank" href="https://www.wsj.com/articles/japan-lifts-covid-19-ban-on-foreigners-entry-but-scars-remain-11645093890">begin to ease</a> pandemic-related travel restrictions next month. The world’s third-largest economy will gradually increase the number of daily arrivals by foreign business travelers and students, from 3,500 to 5,000, and reduce quarantine requirements. Although nearly 60% of Japanese polled<a rel="noopener noreferrer" target="_blank" href="https://www.scmp.com/news/asia/article/3167082/coronavirus-japan-looks-ease-restrictions-even-citizens-support-border"> say</a> they prefer to keep the travel bans in place for now, Prime Minister Fumio Kishida has come under immense pressure from business groups that say restrictions are hobbling the economy. Some 150,000 foreign students have been locked out until now, waiting to put their visas to use. But don’t book that cherry blossom tour just yet: tourists are still not welcome.</p><p><strong>Is Moderna thwarting Africa’s vaccine plans?</strong> Vaccine <a href="https://www.gzeromedia.com/vaccine-politics-and-human-rights">inequality</a> has been a hallmark of the global pandemic. But there was some positive news last week when a South African biotech lab <a rel="noopener noreferrer" target="_blank" href="https://www.politico.eu/article/who-copy-moderna-jab-project-democratize-vaccine-production/">announced</a> it had produced its first batch of mRNA jabs based on publicly available data from American vaccine maker Moderna. After much wrangling with European and American drug makers opposed to waiving <a href="https://www.gzeromedia.com/would-you-get-rid-of-covid-19-vaccine-patents">intellectual property rights</a>, the World Health Organization <a rel="noopener noreferrer" target="_blank" href="https://www.who.int/news/item/21-06-2021-who-supporting-south-african-consortium-to-establish-first-covid-mrna-vaccine-technology-transfer-hub">helped</a> set up the African vaccine hub to address vaccine shortages in low-income countries. But now the Cape Town lab worries that its plans to start human trials by November will be scuttled after Moderna <a rel="noopener noreferrer" target="_blank" href="https://www.reuters.com/business/healthcare-pharmaceuticals/moderna-patent-application-raises-fears-africa-covid-vaccine-hub-2022-02-17/?utm_source=dailybrief&amp;utm_medium=email&amp;utm_campaign=DailyBrief2022Feb17&amp;utm_term=DailyNewsBrief">applied</a> this week for vaccine patents in South Africa. The pharma giant says it won’t enforce any IP rules during the ongoing pandemic, but the African scientists clearly have their doubts. Moderna said last fall that it will spend $500 million to build a <a rel="noopener noreferrer" target="_blank" href="https://www.wsj.com/articles/moderna-to-build-vaccine-manufacturing-plant-in-africa-11633586400">new facility in Africa</a> that could produce up to 500 million vaccine doses per year.</p>]]></content:encoded>
</item>
<item>
<title>Africa’s vaccine cloning gamble</title>
<link>https://www.gzeromedia.com/news/africas-vaccine-cloning-gamble</link>
<guid isPermaLink="false">cmvrerhjwhiby07lqkcrw69e5</guid>
<pubDate>Wed, 27 Oct 2021 22:20:30 +0000</pubDate>
<dc:creator>Carlos Santamaria</dc:creator>
<category>africa</category>
<category>covid-19 vaccine</category>
<category>south africa</category>
<category>pfizer</category>
<category>mrna</category>
<category>biden administration</category>
<category>moderna</category>
<category>News</category>
<description>A South African startup wants to reverse-engineer Moderna&apos;s COVID jab. That would be a huge win for the country and wider unvaxxed Africa, but don&apos;t get too excited just yet.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrayb9k8jh407mytfjso4es" type="image/jpeg" medium="image" width="1054" height="703">
<media:credit>Jess Frampton</media:credit>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrayb9k8jh407mytfjso4es" />
<content:encoded><![CDATA[<p>Less than a year after the world started putting COVID vaccines into people's arms, most regions have immunized at least half their populations, but <a href="https://www.gzeromedia.com/africas-covid-crisis-and-the-politics-of-selfishness">Africa</a> still lags behind. With industrialized nations hoarding jabs and the <a href="https://www.gzeromedia.com/the-covax-state-of-play">COVAX</a> facility faltering, barely five percent of the African population is fully vaccinated.</p><p>Some enterprising South African scientists are now making a bold bid to change that, with an experiment that could benefit not only Africa's 54 nations and billion people, but the entire world: Afrigen Biologics and Vaccines, a Cape Town-based startup, has developed a plan to <a rel="noopener noreferrer" target="_blank" href="https://apnews.com/article/coronavirus-pandemic-technology-business-cape-town-health-48046e5255cc3e4fa27455fc12ab5e52">reverse-engineer</a> Moderna's mRNA shot and manufacture it for priority distribution on the continent.</p><p><strong>How are they going to do it?</strong> The ingredients in Moderna's vaccine "recipe" are mostly publicly available — the trick is to figure out what to do with them. It's like having all the ingredients and measurements to bake a cake, but only vague instructions for each step.</p><p>Given that the Moderna vaccine was developed with US taxpayer money, lawyers are still figuring out which aspects of the process belong solely to the company. But that may be moot for now: the company says it <a rel="noopener noreferrer" target="_blank" href="https://www.bloomberg.com/news/articles/2020-10-08/moderna-won-t-enforce-patents-on-covid-vaccines-during-pandemic">won't sue</a>, leaving Afrigen apparently in the clear to go ahead.</p><p><strong>Cloning an mRNA vaccine would be a huge win for South Africa.&nbsp;</strong>It would be the equivalent of the moon landing in terms of accomplishment and prestige for a nation that too often grabs headlines for all the <a href="https://www.gzeromedia.com/south-africa-rule-of-law-or-cult-of-personality">wrong reasons</a>. Moreover, the project is backed and funded by the World Health Organization, so if the code is cracked, the formula would be made available to all as a public good across the whole continent and the wider developing world.<br><br>A highly effective yet affordable jab that can be manufactured anywhere could be a game-changer to stop more contagious COVID variants from emerging where the population is still unvaccinated. What's more, the sky's the limit when it comes to <a rel="noopener noreferrer" target="_blank" href="https://www.ft.com/content/1f7f349f-d9e0-4b10-aa03-f411328f52ea">mRNA's potential</a> to create vaccines against other diseases endemic to Africa such as Ebola, less infectious but way deadlier than COVID.</p><p><strong>But don't get too excited just yet.&nbsp;</strong>The startup says it'll take up to a year to reverse-engineer Moderna's jab. Also, getting the formula right is only one piece of the puzzle. Afrigen would then need to figure out how to mass-produce, store, and deliver the vaccine around a continent with often poor infrastructure, not to mention getting raw materials at a moment when <a href="https://www.gzeromedia.com/will-biden-be-the-grinch-this-year">global supply chains</a> are already stretched thin.</p><p><strong>There's a political angle too.</strong> In the US, the Biden administration <a rel="noopener noreferrer" target="_blank" href="https://www.axios.com/covid-vaccine-moderna-biden-global-supply-covax-ff74663f-8123-40e1-bc91-f91fdbb92f4c.html?utm_campaign=organic&amp;utm_medium=socialshare&amp;utm_source=twitter">wants</a> Moderna to sell more vaccines to COVAX at cost, and is facing growing <a rel="noopener noreferrer" target="_blank" href="https://twitter.com/gregggonsalves/status/1448982781132947472">criticism</a> for treating the company with kid gloves after ignoring Biden's call to boost production for low-income countries despite Uncle Sam being Moderna's research sugar daddy.</p><p>Meanwhile, public health advocates are urging the National Institutes of Health to <em>force</em> Moderna to <a rel="noopener noreferrer" target="_blank" href="https://www.washingtonpost.com/business/2021/03/25/moderna-vaccine-patent-nih/">give up its secret sauce</a>, and calling out the US government for paying lip service to <a href="https://www.gzeromedia.com/would-you-get-rid-of-covid-19-vaccine-patents">waiving patents</a> and global vaccine equity while not pushing the drugmakers harder to share their tech or prioritize supply for countries with low vaccination rates.</p><p><strong>Technically, the Biden administration has some leverage</strong> because the White House bankrolled Moderna's vaccine research through the NIH and Operation Warp Speed. But twisting Moderna's arm would be a hard sell for the US government, traditionally reticent to meddle with Big Pharma and with little to gain (politically at home) from vaccinating other countries.</p><p>Moderna, for its part, <a rel="noopener noreferrer" target="_blank" href="https://apnews.com/article/coronavirus-pandemic-technology-business-united-nations-europe-d4aff7ddb273194b312354a57c244ce6">says</a> that right now it's better for the company to expand production itself than to <a rel="noopener noreferrer" target="_blank" href="https://www.science.org/doi/10.1126/science.abm8724">share its tech</a> because scaling up production in Africa will take too long. More broadly, it's also playing a longer game of aiming to dominate the post-COVID mRNA manufacturing landscape along with Pfizer.</p><p><strong>No one knows if reverse-engineering mRNA COVID vaccines will work, but then again no one's tried before.</strong> Still, the upshot is that there's a huge opportunity despite uncertainty about the science, the business of producing the jab, and the politics behind it all.</p>]]></content:encoded>
</item>
<item>
<title>NBA player sparks backlash from China; Bolsonaro&apos;s COVID negligence</title>
<link>https://www.gzeromedia.com/video/ask-ian/nba-player-sparks-backlash-from-china-bolsonaro-covid-negligence</link>
<guid isPermaLink="false">cmvrer9qhgoek07mynfifynvp</guid>
<pubDate>Thu, 21 Oct 2021 20:23:32 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>enes kanter</category>
<category>latin america-caribbean</category>
<category>brazil</category>
<category>vaccine equity</category>
<category>moderna</category>
<category>covid-19 vaccine</category>
<category>nba</category>
<category>china</category>
<category>ian bremmer</category>
<category>fda</category>
<category>jair bolsonaro</category>
<category>science-tech</category>
<category>asia</category>
<category>covid-19</category>
<category>boston celtics</category>
<category>elections</category>
<category>pfizer</category>
<category>booster shots</category>
<category>ask ian</category>
<description>China wipes Boston Celtics from NBA broadcast after the &quot;Free Tibet&quot; speech from Enes Kanter. Is NBA boxing itself into a corner? Brazil&apos;s Senate committee accused President Bolsonaro of crimes against humanity for COVID-19 negligence. What&apos;s happening there? FDA is set to approve the &quot;mix and match&quot; approach for COVID booster shots in the US. Will this deepen global vaccine inequality? Ian Bremmer shares his insights on global politics this week.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvraxy048ikp07my1yne1yug" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>NBA Player Sparks Backlash From China | Bolsonaro’s COVID Negligence | World In :60 | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvraxy048ikp07my1yne1yug" />
<content:encoded><![CDATA[<p>Ian Bremmer shares his insights on global politics this week with a look at the NBA's latest rift with China, Brazil's Senate investigation, and COVID booster shots.</p><p><strong>China wipes Boston Celtics from NBA broadcast after the "Free Tibet" speech from Enes Kanter. Is NBA boxing itself into a corner?</strong></p><p>Nice mixed sports metaphor there. NBA has some challenges because they are of course the most progressive on political and social issues in the United States among sports leagues, but not when it comes to China, their most important international market. And you've seen that with LeBron James telling everyone about we need to learn better from the Communist Party on issues like Hong Kong and how Daryl Morey got hammered for taking his stance in favor of Hong Kong democracy. Well, Enes Kanter's doing the same thing and he's a second-string center. Didn't even play yesterday and still the Chinese said that they were not going to air any Boston Celtics games. Why? Because he criticized the Chinese government and had some "Free Tibet" sneakers. This is a real problem for a lot of corporations out there, but particularly publicly, the NBA. Watch for a bunch of American politicians to make it harder for the NBA going forward, saying how dare you kowtow to the Chinese when you're all about "Black Lives Matter" inside the United States. No fun.</p><p><strong>Brazil's Senate committee accused President Bolsonaro of crimes against humanity for COVID-19 negligence. What's happening there?</strong></p><p>Well, they did actually consider accusing him of genocide. They chose not to do that, probably because someone looked into the definition of genocide and realized that that was really stupid. Certainly this is going to make a lot of headlines in Brazil. It's embarrassing for Bolsonaro. None of it's going to pass into law. None of it's going to lead to him being incarcerated or sent to The Hague, but it is one more thing, along with energy price spikes because of drought and their reliance on hydro, because of the economy not doing very well. His popularity right now is in the toilet. It's around 30% and they've got elections next year. Very unlikely that Bolsonaro is able to win. That's the real importance here, is his days are numbered.</p><p><strong>FDA is set to approve the "mix and match" approach for COVID booster shots in the US. Will this deepen global vaccine inequality?</strong></p><p>I don't know if it would deepen it, but it's going to extend it in the sense that we in the United States have been saying publicly that the vaccine..., this pandemic is not over anywhere until it's over everywhere, which is a great thing to say. But of course it's not in any way true in terms of the way we act. The way we act is as long as we've got our Moderna, we've got our Pfizer and we've got our boosters, we get to live like normal again. While around the world, most of the lower-developed countries haven't even gotten their first shot yet. That's the reality around the world. And that's driving much greater mistrust between wealthy countries and poor countries. At the same time, we have our own political differences that are growing inside the United States.</p>]]></content:encoded>
</item>
<item>
<title>What We’re Watching: African vaccine hub, Russia woos Taliban</title>
<link>https://www.gzeromedia.com/news/what-were-watching-african-vaccine-hub-russia-woos-taliban</link>
<guid isPermaLink="false">cmvrequyahgj807lqsd697qlv</guid>
<pubDate>Thu, 07 Oct 2021 17:56:31 +0000</pubDate>
<dc:creator>Carlos Santamaria, Gabrielle Debinski</dc:creator>
<category>afghanistan</category>
<category>asia</category>
<category>africa</category>
<category>russia</category>
<category>ukraine</category>
<category>moderna</category>
<category>covid-19 vaccine</category>
<category>europe</category>
<category>taliban</category>
<category>News</category>
<description>Moderna plans African vaccine hub: Vaccine maker Moderna will spend $500 million to build a new facility in Africa that can produce 500 million annual doses of the company&amp;#39;s COVID jab, which along with Pfizer, uses complex mRNA technology that can&amp;#39;t be easily transferred.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrax81892bo07lqx9iqvsnr" type="image/jpeg" medium="image" width="600" height="400">
<media:credit>REUTERS/Siphiwe Sibeko</media:credit>
<media:text>A person holds a placard as supporters of the Economic Freedom Fighters march to demand a rollout of COVID vaccines, in Pretoria, South Africa.</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrax81892bo07lqx9iqvsnr" />
<content:encoded><![CDATA[<p><strong>Moderna plans African vaccine hub:</strong> Vaccine maker Moderna will spend $500 million to build a <a rel="noopener noreferrer" target="_blank" href="https://www.wsj.com/articles/moderna-to-build-vaccine-manufacturing-plant-in-africa-11633586400">new facility in Africa</a> that can produce 500 million annual doses of the company's COVID jab, which along with Pfizer, uses complex mRNA technology that can't be easily transferred. (Pfizer is already constructing a similar vaccine hub for local production in <a rel="noopener noreferrer" target="_blank" href="https://apnews.com/article/africa-business-health-government-and-politics-coronavirus-pandemic-3367836b55c4dd0fa86d1c6c4cc321cc">South Africa</a>). Indeed, this is great news for the continent, where barely 4 percent of the population has been fully vaccinated, due to lack of supplies coming in from wealthy donor countries and the <a href="https://www.gzeromedia.com/the-covax-state-of-play">COVAX</a> facility. What's more, Moderna plans to use its hub to develop other vaccines against other infectious diseases rife across Africa like Zika or regular influenza. Still, the facility won't be ready for at least two more years, so in the near term African countries will continue relying on foreign suppliers to inoculate their populations against COVID, prolonging the pandemic.</p><p><strong>Kremlin invites Taliban to Moscow:</strong> The Russian government has <a rel="noopener noreferrer" target="_blank" href="https://www.france24.com/en/asia-pacific/20211007-russia-to-invite-taliban-to-international-talks-in-moscow-on-october-20">invited Taliban representatives</a> to participate in summit about the future of Afghanistan on October 20 in Moscow. For the Taliban, inclusion in the meeting — which will be attended by China, India, Iran, and Pakistan — is a boon because they have been vying for <a href="https://www.gzeromedia.com/would-you-recognize-the-taliban">international recognition&nbsp;</a>wherever they can find it. (Much to their dismay, they weren't given a podium at the recent UN General Assembly.) In the wake of the <a href="https://www.gzeromedia.com/what-does-a-taliban-takeover-of-afghanistan-actually-mean">Taliban takeover</a>, Russia is worried about a surge of Islamic militants crossing into former Soviet republics in Central Asia, a buffer zone crucial to Russian national security. The Taliban are deemed a terror group by Russia, but Vladimir Putin has shown a willingness to engage with the group on areas of mutual interest, particularly on <a rel="noopener noreferrer" target="_blank" href="https://thediplomat.com/2021/10/tensions-rise-between-tajikistan-and-the-taliban/">Tajikistan,&nbsp;</a>which borders Afghanistan and hosts Russia's largest overseas military base.</p>]]></content:encoded>
</item>
<item>
<title>GZERO event highlights: IMF chief, G7 vaccine pledges, global health security</title>
<link>https://www.gzeromedia.com/video/gzero-live/gzero-event-highlights-imf-chief-g7-vaccine-pledges-global-health-security</link>
<guid isPermaLink="false">cmvrente1h4rt07lqq9n097bf</guid>
<pubDate>Thu, 10 Jun 2021 12:53:45 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>science-tech</category>
<category>united kingdom</category>
<category>stéphane bancel</category>
<category>europe</category>
<category>noubar afeyan</category>
<category>g7</category>
<category>matt hancock</category>
<category>shery ahn</category>
<category>kristalina georgieva</category>
<category>agnes binagwaho</category>
<category>moderna</category>
<category>ian bremmer</category>
<category>imf</category>
<category>GZERO Live</category>
<description>For IMF Managing Director Kristalina Georgieva (above), a two-track pandemic means a two-track recovery that&apos;ll hurt the entire world in the long run. That&apos;s why she anticipates G7 leaders meeting this week will commit to sending about one billion doses of COVID vaccines to the developing world by the end of the year in new financing and shots unused by wealthy nations. Georgieva hopes it&apos;ll be a summit that gives all countries &quot;a fair short in the arm, a fair shot at the future.&quot; Georgieva was one of many experts who joined this week&apos;s two-part livestream discussion about post-pandemic health security hosted by GZERO Media in partnership with Flagship Pioneering, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvraru2z89ja07mykc7ylyph" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>IMF Chief Kristalina Georgieva Expects 1 Billion COVID Vaccine Doses from G7 | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvraru2z89ja07mykc7ylyph" />
<content:encoded><![CDATA[<p>For IMF Managing Director <strong>Kristalina Georgieva</strong> (above), a two-track pandemic means a two-track recovery that'll hurt the entire world in the long run. That's why she anticipates G7 leaders meeting this week will commit to sending about one billion doses of COVID vaccines to the developing world by the end of the year in new financing and shots unused by wealthy nations. Georgieva hopes it'll be a summit that gives all countries "a fair short in the arm, a fair shot at the future."<br></p><p>Georgieva was one of many experts who joined this week's two-part livestream discussion about post-pandemic health security hosted by GZERO Media in partnership with Flagship Pioneering, <a href="https://www.gzeromedia.com/video/gzero-live/how-will-we-deal-with-the-next-pandemic"><em>Beyond the Pandemic: A Radical New Approach to Health Security</em></a>, presented in partnership with Flagship Pioneering.</p><p>This year's G7 meeting comes at the right time for its members to start thinking together about how to prevent the next pandemic, says UK Secretary of State for Health and Social Care <strong>Matt Hancock</strong>. Part of that conversation, in his view, should focus on how to reform the World Health Organization so it can quickly — and independently — act when the next new pathogen emerges.</p><a href="https://youtu.be/MMybBkjGfzE">https://youtu.be/MMybBkjGfzE</a><p>Why has the much-touted COVAX global facility failed to deliver on its promise of equitable distribution of COVID vaccines despite big pledges from rich nations and multilateral organizations like the IMF? "Don't commit to what you cannot achieve," says <strong>Agnes Binagwaho</strong>, Vice Chancellor at the University of Global Health Equity, who calls out top Western donors for often not walking the talk on commitments — unlike China and India.<br></p><a href="https://youtu.be/N_cSmnwHOFM">https://youtu.be/N_cSmnwHOFM</a><p>When will we need COVID vaccine boosters against new variants? Probably before the fall, according to Moderna CEO <strong>Stéphane Bancel</strong>. And what about IP waivers? He says they are not the solution, and could have negative unintended consequences like stifling future investment in innovative technologies that allowed vaccines to be developed in record time.<br></p><a href="https://youtu.be/V77ke3jU4o8">https://youtu.be/V77ke3jU4o8</a><p>Why is the US not investing huge amounts in health security for Americans and the rest of the world? For <strong>Ian Bremmer</strong>, the government sees value in spending big on national security or tech to counter China, but less so in bolstering our defenses against public health threats. If this continues, he warns, America will be as ill-prepared for the next pandemic as it was for COVID.</p><a href="https://youtu.be/4f6ctB8xXuE">https://youtu.be/4f6ctB8xXuE</a><p>Watch key moments from the first part of this series on June 8, "<a href="https://www.gzeromedia.com/video/gzero-live/highlights-from-our-live-discussion-on-post-pandemic-health-security">Beyond the Pandemic: A Radical New Approach to Health Security,"</a></p><p><a href="https://www.gzeromedia.com/science-tech/"></a>This live event series is produced by GZERO Media in partnership with <a rel="noopener noreferrer" target="_blank" href="https://www.flagshippioneering.com/">Flagship Pioneering</a>. We thank our event partners, <a rel="noopener noreferrer" target="_blank" href="https://www.ahealthieramerica.org/">Partnership for a Healthier America</a> and <a rel="noopener noreferrer" target="_blank" href="https://www.medtronic.com/">Medtronic</a>.</p>]]></content:encoded>
</item>
<item>
<title>How will we deal with the next pandemic?</title>
<link>https://www.gzeromedia.com/video/gzero-live/how-will-we-deal-with-the-next-pandemic</link>
<guid isPermaLink="false">cmvrenslch4pv07lq3k4kq26i</guid>
<pubDate>Wed, 09 Jun 2021 19:53:06 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>james stavridis</category>
<category>amitabh chandra</category>
<category>sundar raman</category>
<category>european union</category>
<category>united kingdom</category>
<category>europe</category>
<category>gargee ghosh</category>
<category>noubar afeyan</category>
<category>matt hancock</category>
<category>geoff martha</category>
<category>shery ahn</category>
<category>kristalina georgieva</category>
<category>stéphane bancel</category>
<category>agnes binagwaho</category>
<category>moderna</category>
<category>ian bremmer</category>
<category>imf</category>
<category>GZERO Live</category>
<description>While most of the world is still grappling with COVID, some countries — mostly wealthy ones with early access to vaccines — are thinking about preparing for the next pandemic. This sentiment ties into a wider debate about health security that was missing when the virus hit us all early last year. Indeed, we should aspire to ensure the health security of our population instead of waiting for it to get sick, Flagship Pioneering CEO Noubar Afeyan said on June 9, during a live discussion, Stronger Partnerships for a Healthier World: Mutually Assured Protection — the second in GZERO Media&apos;s two-part discussion, Beyond the Pandemic: A Radical New Approach to Health Security, presented in partnership with Flagship Pioneering.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarstf8vk207lq4bjj70fm" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>How Will We Deal with the Next Pandemic? | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarstf8vk207lq4bjj70fm" />
<content:encoded><![CDATA[<p>While most of the world is still grappling with COVID, some countries — mostly wealthy ones with early access to vaccines — are thinking about preparing for the next pandemic. This sentiment ties into a wider debate about health security that was missing when the virus hit us all early last year.</p><p>Indeed, we should aspire to ensure the health security of our population instead of waiting for it to get sick, Flagship Pioneering CEO Noubar Afeyan said on June 9, during a live discussion,<strong> </strong><em>Stronger Partnerships for a Healthier World: Mutually Assured Protection</em><strong>&nbsp;</strong>— the second in GZERO Media's two-part discussion, <strong>Beyond the Pandemic: A Radical New Approach to Health Security</strong>, presented in partnership with Flagship Pioneering.</p><p>That'll only be possible with a level of global cooperation that remains absent even during the current pandemic, noted Eurasia Group and GZERO Media President <strong>Ian Bremmer</strong>. Right now, we seem to have learned nothing from COVID, he explained, citing the example of the US, which is more interested in investing on the tech that's on your smartphone to compete with China than in a system to help keep Americans safe from the next virus.</p><p>Also, it's too early to really talk about a global recovery when COVID is still ravaging so many parts of the world. For IMF chief <strong>Kristalina Georgieva</strong>, "a two-track pandemic means a two-track recovery" which will hold the entire planet back for years. She called for all countries to focus on vaccines as the cornerstone of their economic policies, and for rich nations to realize that helping poor ones recover is in their economic interest.</p><p>UK Health Minister <strong>Matt Hancock</strong> said that this week's G7 meeting comes at the perfect time for the world's wealthiest democracies, alongside a few like-minded friends, to make strong commitments on procuring vaccines for low-income nations and donating those they don't need right now. That's fine, but "don't commit to what you cannot achieve," remarked <strong>Agnes Binagwaho</strong>, Vice Chancellor at the University of Global Health Equity, who called out rich countries and multilateral organizations like the IMF for often not walking the talk on their pledges to the developing world.</p><p>Meanwhile, Moderna CEO <strong>Stéphane Bancel</strong> underscored that his goal is to end the pandemic in 2022, not later, and the best hope for that to happen is for governments to help vaccine makers get hold of scarce raw materials instead of demanding patent waivers. It was capital markets and not governments, he added, that Moderna got the money from to conduct the research into mRNA technology to develop COVID jabs in record time.</p><p>Other key moments of the program:</p><ul><li>US Navy Admiral <strong>James Stavridis</strong> (Ret.) on the importance of using military forces to deploy soft power, for instance on vaccine distribution logistics.</li><li>President of Global Policy &amp; Advocacy at the Bill &amp; Melinda Gates Foundation <strong>Gargee Ghosh</strong> on how even enemy governments can collaborate on health, like the US and the Soviet Union did on a smallpox vaccine at the height of the Cold War.</li><li><strong>Geoff Martha</strong>, chairman and CEO of Medtronic, on whether or not we should nationalize certain parts of global supply chains to better deal with the next public health crisis.</li><li>Procter &amp; Gamble President of Global Home Care <strong>Sundar Raman</strong> on how experience in corporate partnerships applies to health security.</li><li><strong>Junaid Bajwa</strong>, chief medical scientist at Microsoft, on the looming shortage of doctors and other medical professionals that'll severely impact our capacity to respond to a public health crisis like a pandemic 10 years from now.</li><li>Nestlé Health Service CEO <strong>Greg Behar</strong> on why we need a three-pronged — regulatory, government, and tech — proactive approach on health security partnerships.</li><li><strong>Amitabh Chandra</strong>, Director of Health Policy Research at the Harvard Kennedy School, on imagining a "parallel universe" in which Pfizer and Moderna had started developing COVID vaccines when the pandemic started, and why vaccine patent waivers are a "death sentence."</li></ul><p>The first day of the series on June 8, <strong>Beyond the Pandemic: A Radical New Approach to Health Security</strong>, <a href="https://www.gzeromedia.com/video/gzero-live/lets-learn-from-covid-to-prevent-the-next-pandemic">discussed what we could learn from COVID to prevent the next pandemic</a>.</p><a href="https://youtu.be/a5ZtbTNlZj4">https://youtu.be/a5ZtbTNlZj4</a><p>This 2-day event was produced by GZERO Media in partnership with <a rel="noopener noreferrer nofollow" target="_blank" href="https://www.flagshippioneering.com/">Flagship Pioneering</a>. We thank our event partners, <a rel="noopener noreferrer nofollow" target="_blank" href="https://www.ahealthieramerica.org/">Partnership for a Healthier America</a> and <a rel="noopener noreferrer nofollow" target="_blank" href="https://www.medtronic.com/us-en/index.html">Medtronic</a>.<br></p>]]></content:encoded>
</item>
<item>
<title>Let&apos;s learn from COVID to prevent the next pandemic</title>
<link>https://www.gzeromedia.com/video/gzero-live/lets-learn-from-covid-to-prevent-the-next-pandemic</link>
<guid isPermaLink="false">cmvrenrtmgbp507mypvsfzafg</guid>
<pubDate>Tue, 08 Jun 2021 22:42:29 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>pfizer</category>
<category>moderna</category>
<category>laurie garrett</category>
<category>albert bourla</category>
<category>ian bremmer</category>
<category>jeh johnson</category>
<category>noubar afeyan</category>
<category>kyriakos mitsotakis</category>
<category>sally davies</category>
<category>lovisa afzelius</category>
<category>paul farmer</category>
<category>GZERO Live</category>
<description>Days before G7 leaders meet in the UK to talk about how to &quot;build back better&quot; after the pandemic, experts are warning them that they should not lose sight of the opportunity to learn from the experience of COVID to be more prepared when the next public crisis hits. Below are a few insights from a livestream discussion between political leaders, policy makers, health experts and scientists, entitled Beyond the Pandemic: A Radical New Approach to Health Security, hosted by GZERO Media in partnership with Flagship Pioneering.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarrey89eb07mytyjdu8xu" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Learning from COVID to Prevent the Next Pandemic | GZERO Media Live</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarrey89eb07mytyjdu8xu" />
<content:encoded><![CDATA[<p>Days before G7 leaders meet in the UK to talk about how to "build back better" after the pandemic, experts are warning them that they should not lose sight of the opportunity to learn from the experience of COVID to be more prepared when the next public crisis hits. Below are a few insights from a livestream discussion between political leaders, policy makers, health experts and scientists, entitled <em>Beyond the Pandemic: A Radical New Approach to Health Security</em>, hosted by GZERO Media in partnership with Flagship Pioneering<em>.</em><em><br></em></p><p>It's time to not just move on, but rather think carefully about pre-empting future pandemics by bolstering health security, said Noubar Afeyan, co-founder of Modern and CEO of the Flagship Pioneering venture capital firm. That would be the best way, he explained, to do justice to the global calls for "never again." For Ian Bremmer, president of Eurasia Group and GZERO Media, the window of opportunity to rally the global cooperation that was virtually absent during the worst of the pandemic is closing fast.</p><p>Science journalist Laurie Garrett blasted global leadership, especially in countries like Brazil and India, for making the pandemic worse with their politicized responses, and for underplaying the importance of preventive public health. Many governments, she pointed out, obliterated their own public health capacity by putting politics first, for instance in the US by demonizing experts such as Dr. Anthony Fauci and weaponizing the probe into the origins of COVID to blame China.</p><p>Prime Minister Kyriakos Mitsotakis offered the lessons Greece has learned from dealing with a massive public health crisis barely after recovering from an economic depression. Mitsotakis also came out in support of the EU's decision to procure vaccines as a bloc over "solidarity," and anticipated that very soon people who still don't want to get vaccinated will realize their lives will become much easier when they agree to get the jab.</p><p>For his part, Pfizer CEO Albert Bourla defended his company's opposition to waiving vaccine patents because the doses are for all — rich or poor, east or west — and that the only reason they can't produce more is because not enough raw materials are now available. Pfizer, he added, is looking into expanding mRNA technology to develop better flu vaccines, those that can boost the immune system to fight non-communicable diseases like cancer, and illnesses that stem from genetic mutations.</p><p>Other key moments of the program:</p><ul><li>Former US Homeland Security chief Jeh Johnson on a possible COVID commission in the US Congress</li><li>Partners in Health founder Paul Farmer on why only former colonial powers are against lifting vaccine patents,</li><li>Dame Sally Davies, England's former chief medical officer, on why we need to think differently about pandemic data</li><li>Partnership for a Healthier America CEO Nancy Roman on the importance of nutrition in preventing unnecessary deaths in any public health crisis</li><li>Lord Ara Darzi (Flagship Pioneering) on why governments need to take public health threats as seriously as national security</li><li>Lovisa Afzelius (Flagship Pioneering) on why we should care about the Global Pathogen Shield.</li></ul><p>Watch the second part of the series, <a href="https://www.gzeromedia.com/video/gzero-live/how-will-we-deal-with-the-next-pandemic"><em>Stronger Partnerships for a Healthier World: Mutually Assured Protection</em></a>, which was recorded live on Wednesday, June 9.</p><p>This live event series was produced by GZERO Media in partnership with <a target="_blank" href="https://www.flagshippioneering.com/">Flagship Pioneering</a>. We thank our event partners, <a target="_blank" href="https://www.ahealthieramerica.org/">Partnership for a Healthier America</a> and <a target="_blank" href="https://www.medtronic.com/">Medtronic</a>.<br></p>]]></content:encoded>
</item>
<item>
<title>Watch our live event: global health beyond the pandemic</title>
<link>https://www.gzeromedia.com/announcements/join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic</link>
<guid isPermaLink="false">cmvrenqnwh4ks07lqgjx7fc5b</guid>
<pubDate>Mon, 07 Jun 2021 23:44:18 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>kyriakos mitsotakis</category>
<category>microsoft</category>
<category>laurie garrett</category>
<category>jeh johnson</category>
<category>stéphane bancel</category>
<category>pfizer</category>
<category>moderna</category>
<category>albert bourla</category>
<category>ian bremmer</category>
<category>matt hancock</category>
<category>noubar afeyan</category>
<category>kristalina georgieva</category>
<category>Announcements</category>
<description>Could the biggest health crisis of our lifetimes actually lead to a healthier world? Watch the second part of our live event series about what public health will look like after the COVID-19 pandemic, presented in partnership with Flagship Pioneering, the bio-platform company that founded Moderna and dozens of other life sciences firms. Days before world leaders G7 meeting, we will bring political leaders and policy makers together with health experts and scientists to discuss lessons learned from and the latest innovations to preempt both COVID-19 variants and future infectious disease pandemics.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarork899q07myaz7eg6ty" type="image/png" medium="image" width="1200" height="675" />
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrarork899q07myaz7eg6ty" />
<content:encoded><![CDATA[<p>Could the biggest health crisis of our lifetimes actually lead to a healthier world? Watch the second part of our live event series about what public health will look like after the COVID-19 pandemic, presented in partnership with Flagship Pioneering, the bio-platform company that founded Moderna and dozens of other life sciences firms.</p><p>Days before world leaders G7 meeting, we will bring political leaders and policy makers together with health experts and scientists to discuss lessons learned from and the latest innovations to preempt both COVID-19 variants and future infectious disease pandemics.</p><p>Attendance is free and open to the public. Please <a href="https://www.gzeromedia.com/video/gzero-live/how-will-we-deal-with-the-next-pandemic">register to attend</a>.</p><p>The virtual event will be hosted by <a rel="noopener noreferrer" target="_blank" href="https://www.flagshippioneering.com/people/noubar-afeyan">Noubar Afeyan</a>, founder &amp; CEO of Flagship Pioneering, and <a rel="noopener noreferrer" target="_blank" href="https://www.eurasiagroup.net/people/ibremmer">Ian Bremmer</a>, president and founder of Eurasia Group and GZERO Media.<br></p><p><strong>Tuesday, June 8, 2021 | 11 AM - 12:30 PM ET </strong><a href="https://www.gzeromedia.com/video/gzero-live/lets-learn-from-covid-to-prevent-the-next-pandemic"><strong>(recording available)</strong></a><strong><br></strong></p><ul><li><strong>Beyond the Pandemic: A Radical New Approach to Health Security:</strong> As the world emerges from the COVID-19 pandemic, what are the lessons learned and how can we use them to not only prepare for, but also preempt the next pandemic? On day one, speakers will discuss new and powerful ways to combat the wide range of threats to our health, including preventing variants and future infectious disease pandemics, and tackling 'slow-burn' pandemics such as obesity and chronic disease. CNBC's Meg Tirrell will moderate the conversation.</li></ul><p><strong>Wednesday, June 9, 2021 | 11 AM - 12:30 PM ET</strong><br></p><ul><li><strong>Stronger Partnerships for a Healthier World: Mutually Assured Protection:</strong> On day two, we'll focus on the need for greater collaboration between governments, international institutions, and the private sector in order to get beyond sick care and create a world where we secure and protect people's health by postponing if not preventing disease, and by promoting good health and wellbeing. Bloomberg TV anchor Shery Ahn will moderate the conversation.</li></ul><p><a target="_blank" href="https://add.eventable.com/events/5f500f1a9890176370fda26f/60a5894097653c35ef2acc3c/">Add to Calendar</a></p><p>Speakers include:<br></p><h2>Kyriakos Mitsotakis</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9esr466az07myuybyyaoh" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593288.png" width="700" height="700"><p>Prime Minister of Greece</p><h2>Kristalina Georgieva</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9esxr6qxe07lqnlklyikf" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593285.png" width="700" height="700"><p>Managing Director, International Monetary Fund</p><h2>Stéphane Bancel</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9et576qxl07lq9fixfqmx" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593289.png" width="700" height="700"><p>CEO, Moderna Therapeutics</p><h2>Agnes Binagwaho</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9etta66c807mysziyku44" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593294.png" width="700" height="700"><p>Vice Chancellor, University of Global Health Equity</p><h2>Geoff Martha</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9eu0k66ct07myet105uk5" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593295.png" width="700" height="700"><p>Chairman &amp; CEO, Medtronic</p><h2>Nancy Roman</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9eu8k6qyd07lquhugtns8" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593297.png" width="700" height="700"><p>President and CEO, Partnership for a Healthier America</p><h2>​Paul Farmer</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9euuc6qyk07lqvjly9pxg" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593304.png" width="700" height="700"><p>Professor, Harvard Medical School; Co-founder, Partners In Health</p><h2>Gargee Ghosh</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ev1n66de07myh01xgt5k" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593308.png" width="700" height="700"><p>President, Global Policy &amp; Advocacy, Gates Foundation</p><h2>Amitabh Chandra</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ev9x66dl07my06ckrfff" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593310.png" width="700" height="700"><p>Professor, Director of Health Policy Research, Harvard Kennedy School</p><h2>Sally Davies</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ew2c6qzh07lqdusuj082" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593437.png" width="700" height="700"><p>GCB DBE, Master of Trinity College</p><h2>Laurie Garrett</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ew8g6qzo07lqyret8ftm" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593429.png" width="700" height="700"><p>Pulitzer Prize-winning journalist</p><h2>Jeh Johnson</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ewgo66et07myyflk8nir" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593431.png" width="700" height="700"><p>Partner, Paul, Weiss, Rifkind, Wharton &amp; Garrison LLP; former Secretary of Homeland Security (2013 - 2017)</p><h2>Albert Bourla</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ewpf6r0g07lq42hz8rxd" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593468.jpg" width="200" height="200"><p>CEO, Pfizer</p><h2>Noubar Afeyan</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9ex3866f407myhjlf8u76" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593497.png" width="254" height="254"><p>President &amp; Founder, Flagship Pioneering</p><h2>Ian Bremmer</h2><img src="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvr9exbr66fb07my37dqu6g0" alt="join-us-live-this-tuesday-and-wednesday-global-health-beyond-the-pandemic-26593498.jpg" width="254" height="254"><p>President &amp; Founder, Eurasia Group and GZERO Media</p><p>Additional speakers include:<br></p><ul><li><strong>Junaid Bajwa</strong>, Chief Medical Scientist, Microsoft</li><li><strong>Matt Hancock</strong>, UK Health Secretary</li><li><strong>James Stavridis</strong>, Admiral, USN (Ret), former Supreme Allied Commander at NATO</li><li><strong>Sundar Raman</strong>, President, Global Home Care and P&amp;G Professional, Procter &amp; Gamble</li><li><strong>Greg Behar</strong>, CEO, Nestle Health Sciences</li></ul><p><a href="https://www.gzeromedia.com/video/gzero-live/how-will-we-deal-with-the-next-pandemic">Register here.</a><br></p><p>This event is produced by <a target="_blank" href="https://www.gzeromedia.com/events/">GZERO Media</a> in partnership with <a target="_blank" href="https://www.flagshippioneering.com/">Flagship Pioneering</a>. We thank our event partners, <a target="_blank" href="https://www.ahealthieramerica.org/">Partnership for a Healthier America</a> and <a target="_blank" href="https://www.medtronic.com/">Medtronic</a>.</p>]]></content:encoded>
</item>
<item>
<title>The race to vaccinate: Dr. Atul Gawande provides perspective</title>
<link>https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/the-race-to-vaccinate</link>
<guid isPermaLink="false">cmvrekuj2gw2t07lqz4pc0mj3</guid>
<pubDate>Mon, 08 Feb 2021 12:30:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>covax</category>
<category>mrna</category>
<category>johnson &amp; johnson</category>
<category>joe biden</category>
<category>covid-19</category>
<category>gzero world</category>
<category>pandemic</category>
<category>us politics</category>
<category>astrazeneca</category>
<category>vaccines</category>
<category>asia</category>
<category>ian bremmer</category>
<category>covid-19 vaccine</category>
<category>moderna</category>
<category>dr. atul gawande</category>
<category>pfizer</category>
<category>science-tech</category>
<category>israel</category>
<category>india</category>
<category>GZERO World with Ian Bremmer</category>
<description>Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramdga8n0707lq81gotvm2" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>The Race to Vaccinate | Biden COVID-19 Adviser, Dr. Atul Gawande | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramdga8n0707lq81gotvm2" />
<content:encoded><![CDATA[<p>Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins Ian Bremmer on GZERO World to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</p>]]></content:encoded>
</item>
<item>
<title>Podcast: The Race to Vaccinate: Dr. Atul Gawande Provides Perspective</title>
<link>https://www.gzeromedia.com/podcast/gzero-world-podcast/the-race-to-vaccinate-podcast</link>
<guid isPermaLink="false">cmvreku4ygw0t07lq6owcav5m</guid>
<pubDate>Sat, 06 Feb 2021 12:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>podcast</category>
<category>ian bremmer</category>
<category>dr. atul gawande</category>
<category>covid-19 vaccine</category>
<category>johnson &amp; johnson</category>
<category>covid-19</category>
<category>moderna</category>
<category>pfizer</category>
<category>mrna</category>
<category>coronavirus mortality rates</category>
<category>coronavirus treatment</category>
<category>joe biden</category>
<category>us politics</category>
<category>GZERO World with Ian Bremmer Podcast</category>
<description>Listen: Can the US vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramda380pz07mywf6jmn47" type="image/jpeg" medium="image" width="640" height="640" />
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvramda380pz07mywf6jmn47" />
<content:encoded><![CDATA[<p><a href="https://www.gzeromedia.com/podcast/gzero-world-podcast/the-race-to-vaccinate-podcast"><strong>Transcript</strong></a></p><p><strong>Listen:</strong> Can the United States vaccinate enough of its population to prevent hundreds of thousands of deaths before new and more contagious COVID-19 variants take hold? And will these vaccines even be effective against more adaptable mutations of the virus? Surgeon and public health expert Dr. Atul Gawande, most recently of the Biden/Harris COVID-19 Transition Task Force, joins the podcast to discuss the latest in the global effort to vaccinate our way out of this pandemic. He also explains why people should get the Johnson &amp; Johnson vaccine if offered the chance, despite its lower overall efficacy rate compared to the mRNA-based vaccines from Pfizer and Moderna.</p><p><em>Subscribe to the GZERO World Podcast on </em><a rel="noopener noreferrer" target="_blank" href="https://podcasts.apple.com/us/podcast/gzero-world-with-ian-bremmer/id1294461271"><em>Apple Podcasts</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://open.spotify.com/show/13QW2sLPCjVbdDE6fmJCNf"><em>Spotify</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://www.stitcher.com/show/gzero-world-with-ian-bremmer"><em>Stitcher</em></a><em>, or your preferred podcast platform to receive new episodes as soon as they're published.</em></p>]]></content:encoded>
</item>
<item>
<title>Operation Warp Speed: Does credit for Moderna’s COVID vaccine go to the US taxpayer?</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/operation-warp-speed-does-credit-for-modernas-covid-vaccine-go-to-the-us-taxpayer</link>
<guid isPermaLink="false">cmvrejtwwgstx07lqzg7ge5oy</guid>
<pubDate>Fri, 18 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19 vaccine</category>
<category>us government funding</category>
<category>united states</category>
<category>operation warp speed</category>
<category>noubar afeyan</category>
<category>biotechnology</category>
<category>science-tech</category>
<category>scientific research</category>
<category>moderna</category>
<category>donald trump</category>
<category>GZERO World Clips</category>
<description>Without the help of the US government initiative &quot;Operation Warp Speed,&quot; Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? &quot;Without caveat,&quot; Afeyan says. He spoke with Ian Bremmer on GZERO World.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakihb7yjs07my6tcgih68" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Operation Warp Speed: Does The Credit for Moderna’s Vaccine Go To the US Taxpayer? | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakihb7yjs07my6tcgih68" />
<content:encoded><![CDATA[<p>Without the help of the US government initiative "Operation Warp Speed," Moderna co-founder Noubar Afeyan says that it would have been impossible for the company to develop and deliver its vaccine so quickly. The fact, he says, that the American people may be days away from receiving its first doses is, in large part, thanks to their taxpayer dollars. Does President Trump, himself, deserve credit? "Without caveat," Afeyan says. He spoke with Ian Bremmer on GZERO World.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"></a><br></p>]]></content:encoded>
</item>
<item>
<title>How development of the COVID-19 vaccine shattered records</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/how-development-of-the-covid-19-vaccine-shattered-records</link>
<guid isPermaLink="false">cmvrejsttg0at07myxe2vogel</guid>
<pubDate>Thu, 17 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19 vaccine</category>
<category>operation warp speed</category>
<category>healthcare</category>
<category>vaccines</category>
<category>biotechnology</category>
<category>epidemiology</category>
<category>pfizer</category>
<category>scientific research</category>
<category>science-tech</category>
<category>moderna</category>
<category>GZERO World Clips</category>
<description>They said it couldn&apos;t be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It&apos;s an unprecedented scientific development in a whirlwind year of crisis.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakggd7ygb07myh3tthfw2" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Ian Explains: How Development of the COVID-19 Vaccine Shattered Records | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakggd7ygb07myh3tthfw2" />
<content:encoded><![CDATA[<p>They said it couldn't be done: a vaccine developed in record time. In 1967, Merck had a license for a mumps vaccine, less than five years for work that normally takes decades. But that record is now being shattered as the COVID-19 vaccine reaches the market in less than a year. It's an unprecedented scientific development in a whirlwind year of crisis.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"></a></p>]]></content:encoded>
</item>
<item>
<title>Does the arrival of Moderna’s vaccine mean we’re back to normal?</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/does-the-arrival-of-modernas-vaccine-mean-were-back-to-normal</link>
<guid isPermaLink="false">cmvrejr7hgsiz07lqcqbogzux</guid>
<pubDate>Wed, 16 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19</category>
<category>pandemic response</category>
<category>covid-19 vaccine</category>
<category>pandemic fatigue</category>
<category>noubar afeyan</category>
<category>coronavirus treatment</category>
<category>science-tech</category>
<category>moderna</category>
<category>vaccines</category>
<category>GZERO World Clips</category>
<description>&quot;I think we&apos;re going to live with the pandemic for much of 2021, but I don&apos;t think it&apos;s a binary thing where we have a pandemic and everything&apos;s awful, or the pandemic&apos;s gone and everything is great again.&quot; Noubar Afeyan, co-founder of the COVID-19 vaccine manufacturer Moderna, levels with Ian Bremmer that even with a vaccine the pandemic will not be gone in a matter of day, weeks, or even months. But that doesn&apos;t mean that everything will be as bleak as it may feel now. Their conversation was part of the latest episode of GZERO World.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakdha7xlz07my2btwy958" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Does the Arrival of Moderna’s Vaccine Mean We’re Back To Normal? | Noubar Afeyan | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakdha7xlz07my2btwy958" />
<content:encoded><![CDATA[<p>"I think we're going to live with the pandemic for much of 2021, but I don't think it's a binary thing where we have a pandemic and everything's awful, or the pandemic's gone and everything is great again." Noubar Afeyan, co-founder of the COVID-19 vaccine manufacturer Moderna, levels with Ian Bremmer that even with a vaccine the pandemic will not be gone in a matter of day, weeks, or even months. But that doesn't mean that everything will be as bleak as it may feel now. Their conversation was part of the latest episode of GZERO World.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a><a target="_blank" href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"></a></p>]]></content:encoded>
</item>
<item>
<title>What are the “known unknowns” about Moderna’s vaccine?</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/what-are-the-known-unknowns-about-modernas-vaccine</link>
<guid isPermaLink="false">cmvrejpuggse707lq2sfd0jkm</guid>
<pubDate>Tue, 15 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>influenza</category>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19</category>
<category>zika virus</category>
<category>moderna</category>
<category>coronavirus treatment</category>
<category>covid-19 vaccine</category>
<category>pandemic</category>
<category>noubar afeyan</category>
<category>vaccines</category>
<category>scientific research</category>
<category>cytomegalovirus</category>
<category>science-tech</category>
<category>GZERO World Clips</category>
<description>Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn&apos;t know about his company&apos;s COVID-19 vaccine, just as there&apos;s plenty he still doesn&apos;t know about the virus. But he is confident about one thing: &quot;I view the vaccine as the best mask. It&apos;s a molecular mask, and once we have it onboard once, then presumably it will protect us.&quot; His conversation with Ian Bremmer was part of the latest episode of GZERO World.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakb3l8jhy07lqnmubv980" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>What Are the “Known Unknowns” About Moderna’s Vaccine? | Noubar Afeyan | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrakb3l8jhy07lqnmubv980" />
<content:encoded><![CDATA[<p>Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"></a><br></p>]]></content:encoded>
</item>
<item>
<title>Moderna’s co-founder Noubar Afeyan on the growing pushback against a COVID-19 vaccine</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/modernas-co-founder-noubar-afeyan-on-the-growing-pushback-against-a-covid-19-vaccine</link>
<guid isPermaLink="false">cmvrejouwgs9207lqm2iysd3j</guid>
<pubDate>Mon, 14 Dec 2020 18:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19</category>
<category>moderna</category>
<category>pandemic</category>
<category>vaccine safety</category>
<category>vaccine hesitancy</category>
<category>covid-19 vaccine</category>
<category>noubar afeyan</category>
<category>vaccines</category>
<category>science-tech</category>
<category>GZERO World Clips</category>
<description>&quot;In any debate, if one side has to offer facts and the other side can offer doubts and they&apos;re considered of equal value, then the ones who offer doubts will always have an advantage.&quot; Moderna co-founder Noubar Afeyan isn&apos;t naïve about the pushback that his company&apos;s COVID-19 vaccine will receive when it hits the US market. Disinformation around vaccine safety and efficacy was rampant even before the pandemic began. His conversation with Ian Bremmer was part of the latest episode of GZERO World.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak9aw7xhs07my4s9qikcu" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Moderna’s Co-Founder Noubar Afeyan On the Growing Pushback Against a COVID-19 Vaccine | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak9aw7xhs07my4s9qikcu" />
<content:encoded><![CDATA[<p>"In any debate, if one side has to offer facts and the other side can offer doubts and they're considered of equal value, then the ones who offer doubts will always have an advantage." Moderna co-founder Noubar Afeyan isn't naïve about the pushback that his company's COVID-19 vaccine will receive when it hits the US market. Disinformation around vaccine safety and efficacy was rampant even before the pandemic began. His conversation with Ian Bremmer was part of the latest episode of GZERO World.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna’s Co-Founder on the COVID-19 Vaccine</strong></a><br></p>]]></content:encoded>
</item>
<item>
<title>A shot in the arm: Moderna’s co-founder on the COVID-19 vaccine</title>
<link>https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives</link>
<guid isPermaLink="false">cmvrejoo8gs8507lqno7lt7b1</guid>
<pubDate>Mon, 14 Dec 2020 13:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>gzero world</category>
<category>ian bremmer</category>
<category>noubar afeyan</category>
<category>moderna</category>
<category>covid-19 vaccine</category>
<category>covid-19</category>
<category>mrna</category>
<category>biotechnology</category>
<category>covid vaccine development</category>
<category>GZERO World with Ian Bremmer</category>
<description>Ian Bremmer interviews Noubar Afeyan, the co-founder of leading vaccine developer Moderna. They discuss distribution plans, the revolutionary science behind Moderna&apos;s vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak8s57xgk07my8iszlz9g" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>A Shot In The Arm: The COVID-19 Vaccine Arrives | Moderna Co-Founder Noubar Afeyan | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak8s57xgk07my8iszlz9g" />
<content:encoded><![CDATA[<p>The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On GZERO World, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</p>]]></content:encoded>
</item>
<item>
<title>Podcast: COVID Vaccine in Record Time - What Now? Moderna Co-Founder Noubar Afeyan</title>
<link>https://www.gzeromedia.com/podcast/gzero-world-podcast/covid-vaccine-in-record-time-what-now-podcast</link>
<guid isPermaLink="false">cmvrejnbxgs2z07lq77cs1v08</guid>
<pubDate>Sat, 12 Dec 2020 11:00:00 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>ian bremmer</category>
<category>podcast</category>
<category>covid-19 vaccine</category>
<category>covid-19</category>
<category>pandemic</category>
<category>noubar afeyan</category>
<category>biotechnology</category>
<category>mrna</category>
<category>science-tech</category>
<category>scientific research</category>
<category>moderna</category>
<category>GZERO World with Ian Bremmer Podcast</category>
<description>Listen: The pandemic&apos;s US death toll shows no signs of abating and the holiday season&apos;s spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World Podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They&apos;ll discuss distribution plans, the revolutionary science behind Moderna&apos;s vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak6cr8jcx07lql97q37pw" type="image/jpeg" medium="image" width="640" height="640" />
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak6cr8jcx07lql97q37pw" />
<content:encoded><![CDATA[<p><a href="https://www.gzeromedia.com/podcast/gzero-world-podcast/covid-vaccine-in-record-time-what-now-podcast"><strong>Transcript</strong></a></p><p><strong>Listen:&nbsp;</strong>The pandemic's US death toll shows no signs of abating and the holiday season's spike will likely dwarf any surge that came before it. But in the midst of this dark winter there are glimmers of hope, as the first of the COVID-19 vaccines have nearly arrived (or, depending on when you read this, already have). On the GZERO World podcast, Ian Bremmer interviews Noubar Afeyan, the co-founder of a leading vaccine developer Moderna. They'll discuss distribution plans, the revolutionary science behind Moderna's vaccine, and how a company younger than Twitter became a frontrunner in the race to end the pandemic.</p><p><em>Subscribe to the GZERO World Podcast on </em><a rel="noopener noreferrer" target="_blank" href="https://podcasts.apple.com/us/podcast/gzero-world-with-ian-bremmer/id1294461271"><em>Apple Podcasts</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://open.spotify.com/show/13QW2sLPCjVbdDE6fmJCNf"><em>Spotify</em></a><em>, </em><a rel="noopener noreferrer" target="_blank" href="https://www.stitcher.com/show/gzero-world-with-ian-bremmer"><em>Stitcher</em></a><em>, or your preferred podcast platform to receive new episodes as soon as they're published.</em></p>]]></content:encoded>
</item>
<item>
<title>How the Moderna vaccine works, why it’s effective, and how it’ll be distributed</title>
<link>https://www.gzeromedia.com/video/gzero-world-clips/how-the-vaccine-works-why-its-effective-and-how-itll-be-distributed</link>
<guid isPermaLink="false">cmvrejmjyfzw207myo1w5tb00</guid>
<pubDate>Fri, 11 Dec 2020 01:18:42 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>covid-19 vaccine</category>
<category>science-tech</category>
<category>ian bremmer</category>
<category>gzero world</category>
<category>covid-19</category>
<category>mrna</category>
<category>moderna</category>
<category>noubar afeyan</category>
<category>biotechnology</category>
<category>GZERO World Clips</category>
<description>&quot;What we&apos;re trying to do is to educate the immune system to see the protein before it&apos;s seen the virus.&quot; In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10 months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains. His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak4y77x4w07myiatbmnkj" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>How the Moderna Vaccine Works, Why It’s Effective, and How It’ll Be Distributed | GZERO World</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrak4y77x4w07myiatbmnkj" />
<content:encoded><![CDATA[<p>"What we're trying to do is to educate the immune system to see the protein before it's seen the virus." In a race for a COVID vaccine, Moderna, a 10-year old company with no products previously on the market, developed a vaccine in 10-months, by using revolutionary new mRNA technology. Now the focus shifts to how to distribute and safely administer this vaccine. Moderna co-founder and chairman Noubar Afeyan explains.</p><p>His conversation with Ian Bremmer was part of the latest episode of GZERO World, which began airing nationally in the US on public television Friday, December 11th. Check local listings.</p><p><em>Watch the GZERO World episode:&nbsp;</em><a href="https://www.gzeromedia.com/video/gzero-world-with-ian-bremmer/a-shot-in-the-arm-the-covid-19-vaccine-arrives"><strong>A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine</strong></a></p>]]></content:encoded>
</item>
<item>
<title>US bet on Pfizer and Moderna may lead to earlier COVID vaccine rollout</title>
<link>https://www.gzeromedia.com/video/ask-ian/us-bet-on-pfizer-and-moderna-may-lead-to-earlier-covid-vaccine-rollout</link>
<guid isPermaLink="false">cmvrejfitfzej07myesa7s3jv</guid>
<pubDate>Wed, 02 Dec 2020 00:47:30 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>in 60 seconds</category>
<category>art</category>
<category>science-tech</category>
<category>astrazeneca</category>
<category>pfizer</category>
<category>european union</category>
<category>europe</category>
<category>geopolitics</category>
<category>covid-19 vaccine</category>
<category>united states</category>
<category>moderna</category>
<category>ian bremmer</category>
<category>covid-19</category>
<category>us vaccine rollout</category>
<category>ask ian</category>
<description>Ian Bremmer shares his perspective on global politics on this week&apos;s World In (More Than) 60 Seconds: With COVID vaccine near, what will the distribution look like across the world? Why is everyone on Twitter talking about monoliths?</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrajruw8ixc07lqme0c4eer" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>US Bet On Pfizer and Moderna May Lead to Earlier COVID Vaccine Rollout | World In :60 | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrajruw8ixc07lqme0c4eer" />
<content:encoded><![CDATA[<p>Ian Bremmer shares his perspective on global politics on this week's World In (More Than) 60 Seconds:</p><p><strong>With COVID vaccine near, what will the distribution look like across the world?</strong></p><p>Well, yeah, it is quite near. I mean, we're talking about approvals coming just in the next few days for the first in the United States and indeed in other countries around the world. That means that within weeks, you're going to know people that have actually gotten vaccines, and that's pretty exciting, especially with Moderna and Pfizer showing 95% effectiveness. I guess there are a few things that I would say. The first, hearing from the coronavirus task force that everyone in the United States gets the vaccine that wants to take it by June. I think that's right. I mean, there could be infrastructure and delivery hiccups. I hope there won't be. Everyone is going to be rowing in more or less the same direction on this because everyone understands how important it is to get it done.</p><p>I'm going to say it again. I don't think you're going to see a lot of people playing politics around taking the vaccine. There are anti-vaxers out there. I've already heard from a bunch of them, but you're not seeing that from Trump or his top advisors. You're not seeing that from Biden and from his incoming coronavirus task force. In the United States where everything gets politicized, a lot of people are going to be taking this coronavirus vaccine. And indeed, you already see numbers of people and their skepticism has been reduced significantly just in the last couple of weeks as we're learning more about it. I certainly feel much more comfortable that I will take these vaccines as soon as they are properly available to me. I'm not sure I would've said that three months ago, given where we were at that point. I feel very comfortable with that now. So that's number one.</p><p>Number two, the United States has bought as much as possible of not only the Pfizer and Moderna vaccines, but other vaccines too. And the reason they do that is because when you see start making those orders, you don't know which vaccines are going to work. Because the Europeans have bet more strongly on AstraZeneca, which is a vaccine that has had problems in testing and doesn't do as well, that implies to me that the Americans are going to be getting this rollout before the Europeans do. And that will have economic implications for getting economies back up and rolling early next year. So the US does have a structural advantage here.</p><p>Also, final point. Let's keep this in mind. Those two vaccines in the United States are really vaccines that are most useful for advanced industrial economies, because they require much stronger infrastructure. You've got booster shots you need to deliver and you also have to have not just regular refrigeration, but more advanced cold chain technology. You're not using that in most of the developing world. The Chinese are going to be doing most of the early-stage export of their less effective, but still effective, vaccine to the developing world. Just needs regular refrigeration. And that's a lot of influence. I think you're going to see an enormous amount of politics play out as we see Chinese export to the developing world. And if you think that people are concerned about Belt and Road and the Asian Infrastructure Investment Bank, you've seen nothing before the kind of leverage the Chinese influence over their best friends who get their vaccines earlier than other countries do and what they want in return.</p><p>This is also going to be one of the biggest challenges for the United States and China in terms of navigating the relationship. I mean, a lot of people think that the US-China relationship is going to be at least more normalized, maybe a little bit better, maybe more promising under Biden. I'm not sure. I see the outbreak of serious trade confrontation and diplomatic confrontation with Australia right now. I see it with Canada right now. I see so many countries that are really antagonized by the Chinese government. And I see these issues getting worse. So even with a group that's rowing in the same direction as the Biden administration will, and with tweets not driving people crazy, I suspect this relationship is going to be very challenging. And I think vaccine rollout is going to be a big problem. So that was a lot of time on your question, but it's a really important question.</p><p><strong>Why is everyone on Twitter talking about monoliths?</strong></p><p>I have no idea. Some artists installed some metallic thing in the middle of Utah that nobody saw for awhile, despite satellite technology. Why not? Why did no one notice? Aren't there people that spend all their time just looking at the land and seeing what's new? You'd think that AI would have figured that out, but no. No, apparently nobody noticed it, and then suddenly in person they did, and then the obelisk is gone. And I honestly don't care. And we're going to find out that it's... Remember the guy that took the banana and nailed the banana to the side of a wall and said it was an art installation and was charging $80,000? And some other crisis actor came and took down the banana and ate it. And the whole thing was a set up?</p><p>It is kind of is annoying. I mean, at least Banksy does it with real talent. The banana guy just did it with a stupid banana. Right? I mean, I don't consider that art and this obelisk is kind of a stupid obelisk, and I don't consider that art either. This is probably the most controversial thing I'm going to say all day. So come at me haters. I don't care. I'm just not interested in a stupid obelisk. The only thing would make me less interested in it is if you put it in Rhode Island. How's that? And drew cats on it. That would really annoy me. But they haven't done that. It's just a stupid obelisk, but it's on my list of things that I find annoying. So there you go.</p>]]></content:encoded>
</item>
<item>
<title>Quick Take: Latest vaccine news may be a light at the end of the tunnel</title>
<link>https://www.gzeromedia.com/video/quick-take/latest-vaccine-news-may-be-a-light-at-the-end-of-the-tunnel-quick-take</link>
<guid isPermaLink="false">cmvrejbn6grbe07lq87hz1lwv</guid>
<pubDate>Mon, 23 Nov 2020 23:54:50 +0000</pubDate>
<dc:creator>GZERO Staff</dc:creator>
<category>us-china relations</category>
<category>geopolitics</category>
<category>johnson &amp; johnson</category>
<category>operation warp speed</category>
<category>economic crisis</category>
<category>pandemic</category>
<category>middle-east</category>
<category>benjamin netanyahu</category>
<category>astrazeneca</category>
<category>covid-19 vaccine</category>
<category>ian bremmer</category>
<category>covid-19</category>
<category>africa</category>
<category>joe biden</category>
<category>ethiopia</category>
<category>mohammed bin salman</category>
<category>antony blinken</category>
<category>moderna</category>
<category>quick take</category>
<category>pfizer</category>
<category>donald trump</category>
<description>Ian Bremmer&apos;s Quick Take: Hey, everybody. Ian Bremmer here, happy Monday, Thanksgiving week. Things starting to look increasingly normal in terms of outlook, in terms of having all of these vaccines. I understand that the next few months in the United States are going to be incredibly challenging, but so much easier when you see that there&apos;s light at the end of the tunnel and you know where that&apos;s coming. Most recently, the AstraZeneca announcement, which for me, in some ways is a bigger deal globally, even than what we&apos;ve seen from Moderna and Pfizer.</description>
<media:content url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrajkow8irg07lqfsx16yeg" type="image/jpeg" medium="image" width="1280" height="720">
<media:credit>youtu.be</media:credit>
<media:text>Ian Bremmer: Latest Vaccine News May Be a Light at the End of the Tunnel | Quick Take | GZERO Media</media:text>
</media:content>
<media:thumbnail url="https://us-west-2.graphassets.com/cmrcgvnh6064507n8hhitfmjj/cmvrajkow8irg07lqfsx16yeg" />
<content:encoded><![CDATA[<p><strong>Ian Bremmer's Quick Take:</strong></p><p>Hey, everybody. Ian Bremmer here, happy Monday, Thanksgiving week. Things starting to look increasingly normal in terms of outlook, in terms of having all of these vaccines. I understand that the next few months in the United States are going to be incredibly challenging, but so much easier when you see that there's light at the end of the tunnel and you know where that's coming. Most recently, the AstraZeneca announcement, which for me, in some ways is a bigger deal globally, even than what we've seen from Moderna and Pfizer, because it doesn't require freezing, it's just refrigeration, which means that countries around the world that don't have the infrastructure to deal with this cold chain requirements of these vaccines will be able to use another set of vaccines with different technology. That's not just AstraZeneca, it will be Johnson and Johnson. It's the Russians. It's the Chinese.</p><p>As you start rolling those out, that allows the world to actually get back to normal. It's going to take longer than the United States and Europe and Japan. The advanced industrial economies are going to get these vaccines first, they've put the money in, they've done the development, they have the infrastructure, but we're not talking about years, we're talking about months. By the time we get to first quarter next year, large numbers of people are actually going to be vaccinated. I also think it's really important that this is an issue that is not getting politicized. I mean, yes, there's the potential for fights among states, especially states that have difficulties in terms of how much money they have and can allocate to getting this infrastructure up and running. It's expensive, it'll take billions of dollars, and a lot of states are already got big budget deficit crunches, and you're going to have Democrats versus Republicans fighting over where money is and isn't going and difficulties and stimulus, all of that.</p><p>But the fact that these vaccines have been developed by or supported by Operation Warp Speed in the US, means that both the outgoing Trump administration and the incoming Biden administration are all going to be saying, "Get these vaccines." I mean, there will be anti-vaxxer sentiment in the world, and there will be anti-vaxxer sentiment in the United States. But when your top vaccines are at 95% effectiveness, and when the side effects are largely limited to a fever for a few days, but not more significant than that, more people are going to take it. When both Republicans and Democrats, when political leaders around the world are all saying, "Take it." This isn't like, is a mask useful or not? Should have never been politicized in the US. What about hydroxychloroquine? That works, or no, it really doesn't. Remdesivir it works, no it really doesn't.</p><p>These things have gotten politicized and they make people not believe it. I don't think people will feel that way about the vaccines. I'm worried that in some countries, Israel and France, the level of anti-vax sentiment and the disinformation around vaccines is very high. Russia, believe it or not, highest level of disinformation and anti-vax sentiment in the world, even though the Russians themselves are one of the producers that are pushing to get these vaccines out as fast as possible, a lot of Russians will refuse to take it, but I think the numbers will be lower than you expect. So if you add to the fact that you're going to have lots of vaccines available soon at very high efficacy, not getting politicized, more people believing in it, and a lot of people that will have already gotten the disease. I mean, in the United States right now, we know that a large percentage of the population has already gotten the disease.</p><p>Let's say 5%, but in reality, that's tested, given limitations of tests and level of asymptomatic spread. In reality, it's probably more like 15% of Americans have already gotten coronavirus. Once we start talking about end of winter and what this present second wave looks like, you're probably talking about closer to 25 or 30%. So you have 25 or 30% of the population has already gotten coronavirus, whether they know it or not, and have some level of immunity. Then you're able to get a meaningful piece of the population taking this vaccine, especially those that are most vulnerable to dying. Your mortality rate from coronavirus by spring is going way down. That's on top of all of the improvements with treatments that we've gotten with better ability to recognize quickly symptoms, both in-home treatments and in-hospital treatments and these antigen cocktails also getting approved. We see from Eli Lilly, we see others, the Regeneron, those are also making a significant difference in terms of improved treatment and lowering mortality rates.</p><p>You put that all together by middle of next year, we're starting to look at coronavirus in the rear view mirror. It's still an issue, it's still with us, and it's still a global problem, but it's no longer stopping us from engaging in big pieces of our daily lives. My God, that's great news. It's bigger news then the election in the United States, I've said it before, I'll say it again. Coronavirus is absolutely the most important issue in the United States and globally. It was true before the election. It's true after the election, a lot of people going insane because Trump refuses to concede. He may never concede. He's still leaving. Yes, it's a problem that we've got all this disinformation in the media, but that's very different from being able to respond in short order, in a year, to a disease that did not exist in the human population just over a year ago, has infected, we know of, some 50 plus million people around the world. Again, reality much greater than... suddenly we can address it. That's the news! That's the news!</p><p>Lots of other things going on, obviously, and I'll be spending more time on them. It'll be good to get back to daily, international affairs. The fighting that we see in Ethiopia, which is getting worse and a lot of hard liners in the Ethiopian government that the Abiy administration needs to stay in power, but pushing towards efforts against the Tigray region that could amount to war crimes. I hope they don't start shelling the general population. We've already seen lots and lots, I mean, 5,000 a day refugees, those numbers could pick up, it's a big new war and it's in a country that has over 100 million people, that's a pretty big deal. So got to watch out for that.</p><p>Certainly worried about the potential for US, China relations to continue to deteriorate. Trump is still President for a couple of months and there will be further measures taken against the Chinese government. There are plenty of things the Chinese government's doing that are antagonizing, not just the US, but other countries around the world, that has the potential to get worse. Also, of course, the fact that there's just been a meeting between the Saudi Crown Prince and the Prime Minister of Israel, both have their domestic challenges. Netanyahu may not be very long for power in Israel, MBS has had his internal fights and trying to consolidate power inside Saudi Arabia, and clearly worries that a Biden administration will not be as interested in working with him as the Trump administration has. But we're talking about a completely new geopolitics in the Middle East that allows America's allies in the region to work more closely with each other, puts more pressure on Iran at the margins, makes it easier to get back to a new tweaked Iranian nuclear deal.</p><p>By the way, my friend, Tony Blinken who's about to be appointed Secretary of State, he is someone who clearly understands that if you're going to get back to the Iranian deal, you're not doing the status quo ante, it's going to be more challenging. So the Saudi Israel alignment, which Secretary of State Pompeo was involved in, frankly, I mean, I'm sure that Pompeo and Blinken are not talking to each other right now, but I'd like to hope in the coming weeks, maybe they will, because they're both rowing in the same direction. This is an area where the American national security interest is the same, whether you're talking about Trump or whether you're talking about Biden, there's more of that than people generally think or appreciate it. So that's a little bit from me. Thanks everyone, be good.</p>]]></content:encoded>
</item>
</channel>
</rss>